Clinical Trial Update: Lopinavir/Ritonavir Monotherapy Versus Standard Highly Active Antiretroviral Therapy (HAART) in HIV/HCV Coinfected Patients Starting Treatment With Anti-Hepatitis C Virus (HCV) Therapy [Phase 3]

View source ↗

Summary

This Phase 3 clinical trial compares lopinavir/ritonavir monotherapy to standard HAART in HIV/Hepatitis C coinfected patients starting anti-HCV therapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Hepatitis C

Drugs mentioned

• Lopinavir/ritonavir (Kaletra) (lopinavir/ritonavir)

Snippet

Sponsor: IRCCS San Raffaele | Conditions: HIV Infections, Hepatitis C | Phase 3 | Status: UNKNOWN